Vivimed Labs Limited has informed the Exchange regarding 'Annual secretarial compliance report'.
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivimed Labs Limited has filed its Annual Secretarial Compliance Report for FY 2025-26, certified by Practicing Company Secretary N.V.S.S. Suryanarayana Rao. The report indicates that the company largely complied with SEBI regulations including LODR, PIT, and SAST. However, one deviation was noted: the company failed to submit quarterly financial results for Q3 FY2025 (December 2025) within the prescribed timeline. The delay was attributed to the resignation of the company's CFO on February 6, 2026. As a result, BSE and NSE imposed a combined fine of Rs. 2,95,000 under their Standard Operating Procedures. No other non-compliances or regulatory actions against the company, its promoters, directors, or subsidiaries were reported.
The fine is a minor regulatory penalty stemming from a one-time operational issue related to CFO transition. This is unlikely to have significant impact on the stock but reflects a compliance lapse that investors should be aware of.